Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes



Wiviott, SD, Raz, I, Bonaca, MP, Mosenzon, O, Kato, ET, Cahn, A, Silverman, MG, Zelniker, TA, Kuder, JF, Murphy, SA
et al (show 11 more authors) (2019) Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE, 380 (4). 347 - 357.

[img] Text
nejmoa1812389.pdf - Accepted Version

Download (421kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 22 Nov 2018 10:36
Last Modified: 03 Dec 2021 19:10
DOI: 10.1056/NEJMoa1812389
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3029005